Jennerex Biotherapeutics jennerex.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead product JX-594, currently in an international Phase II trial for primary liver cancer, demonstrated promising Phase I efficacy and safety results in patients with a diverse array of common large market cancers. Jennerex's products target, attack and eradicate cancers through a novel and potent oncolytic ...Show all

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead product JX-594, currently in an international Phase II ...Show all

Company (Acquired)

Phone: 415-281-8886

Fax:

450 Sansome Street
16th Floor
San Francisco, 94111
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Jennerex Biotherapeutics $70.5M Mar 18, 2014
Allos Therapeutics $235.6M Sep 7, 2012
Poniard Pharmaceuticals $99.1M Apr 18, 2006
See all 24 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Jennerex Biotherapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

Competitors

Company Status Description Investors
See all 24 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Oncolytic vaccinia virus combination cancer therapy May 08, 2014 Nov 10, 2015 Patent
Methods and compositions concerning poxviruses and cancer Nov 13, 2012 Mar 24, 2015 Patent
Oncolytic vaccinia virus combination cancer therapy Sep 14, 2010 Jun 10, 2014 Patent
Methods and compositions concerning poxviruses and cancer Aug 14, 2007 Dec 11, 2012 Patent